Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2023-04-24 Capital/Financing Update
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Outcome of the board meeting held on 24.4.2023
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. It details a share purchase agreement (SPA) between a promoter and an acquirer involving a significant acquisition of shares (33.38%) in Unichem Laboratories Limited. The document includes specifics about the transaction, conditions precedent, and regulatory approvals required, as well as disclosures related to the transaction. It is an announcement of a capital transaction involving share acquisition and control change, not a full financial report or earnings release. The content fits the category of Capital/Financing Update (CAP) as it relates to a significant change in shareholding and capital structure through a share purchase agreement and takeover offer obligations under SEBI regulations.
2023-04-24 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding compliance with Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It specifically informs about the loss/misplacement of share certificates and the subsequent issuance of a letter of confirmation in lieu of duplicate share certificates. There is no financial data, no report attached or referenced as being published, and no mention of management changes, voting results, or other report types. This is a regulatory compliance notification related to share certificate loss, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories.
2023-04-19 English
Intimation about the loss/misplacement of Share Certificate(s), as received from Link Intime India Pvt Ltd, the Registrar & Share Transfer Agents of Company.
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to stock exchanges regarding compliance with Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It specifically informs about the loss/misplacement of share certificates and the subsequent issuance of a letter of confirmation in lieu of duplicate share certificates. There is no financial data, report, or presentation included. The content is a regulatory compliance notification related to share certificates, which fits the category of Regulatory Filings (RNS) as it does not fall under any other specific category such as share issue, director dealings, or dividend announcements.
2023-04-19 English
Certificate under regulation 40(9) & 40 (10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended for the financial year ended March 31, 2023.
Regulatory Filings
2023-04-18 English
Price movement
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges clarifying that there is no unpublished price sensitive information affecting the company's share price. It is a regulatory disclosure responding to an inquiry about price movement, referencing compliance with SEBI (LODR) Regulations. The document is short (1607 characters) and does not contain financial data, reports, or detailed analysis. It is not a financial report, earnings release, or management discussion. It is a regulatory filing providing clarification to the exchange, fitting best under the Regulatory Filings (RNS) category as a general compliance disclosure.
2023-04-14 English
Clarification on price movement
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges clarifying that there is no unpublished price sensitive information affecting the company's share price. It is a regulatory disclosure responding to an inquiry about price movement. The document does not contain financial statements, management discussion, or detailed report data. It is a compliance communication under SEBI (LODR) Regulations. The length is short (1607 characters) and it is not a report or announcement of a report publication. This fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2023-04-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.